816303

Boehringer Ingelheim Pharmaceuticals, Inc. — FEI 1219205

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 30, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ridgefield, CT (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures